• Home
  • The MEK inhibitor trametinib separates murine graft-versus-host disease from graft-versus-tumor effects.

The MEK inhibitor trametinib separates murine graft-versus-host disease from graft-versus-tumor effects.

Author List
Itamura H, Shindo T, Tawara I, Kubota Y, Kariya R, Okada S, Komanduri KV, Kimura S
Publication
JCI insight
Publication ID (Profile URL)
https://researcherprofiles.org/profile/314409035
Publication Year
2016
PubMed ID
27699218
Publication Title
Itamura H, Shindo T, Tawara I, Kubota Y, Kariya R, Okada S, Komanduri KV, Kimura S. The MEK inhibitor trametinib separates murine graft-versus-host disease from graft-versus-tumor effects. JCI Insight. 2016 07 07; 1(10):e86331.